SHANGHAI PH.H UNSP.ADR/5 ADR Logo
US81943R1005
A3C7PX

SHANGHAI PH.H UNSP.ADR/5 ADR

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2026, SHANGHAI PH.H UNSP.ADR/5 ADR has already paid €0.29 in dividends. The last payout was in September.

Financials

In the last quarter, SHANGHAI PH.H UNSP.ADR/5 ADR had revenue of €9.29B and net profit of €268.36M
(EUR) June 2026
YoY
Revenue 9.29B 10.71%
Gross profit 990.89M 9.00%
Net profit 268.36M 27.51%
EBITDA 426.67M 20.37%

Fundamentals

Metric Value
Market capitalization
€4.56B
Number of shares
741.67M
52-week high/low
€7.35 - €5.72
Dividend yield
4.17%
Dividends TTM
€0.29
Next dividend
€0.0663
Beta
0.16
P/E ratio
12.53
PEG ratio
-0.60
P/B ratio
0.77
P/S ratio
0.19

Company profile

Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

Name
SHANGHAI PH.H UNSP.ADR/5 ADR
CEO
Qiuhua Yang
Website
IPO
02/19/2014
Employees 49,608
🍪

Parqet  uses cookies. Learn more